Aliskiren monotherapy lowers blood pressure more effectively than ramipril monotherapy in patients with diabetes and grade 2 hypertension: Subgroup analysis of an 8-week, double-blind trial

dc.contributor.author	Lukashevich, V.
dc.contributor.author	Uresin, Y.
dc.contributor.author	Kilo, C.
dc.contributor.author	Fang, H.
dc.contributor.author	Keefe, D. L.
dc.contributor.author	Taylor, A. A.
dc.date.accessioned	2021-03-04T11:41:20Z
dc.date.available	2021-03-04T11:41:20Z
dc.identifier.citation	Uresin Y., Taylor A. A. , Kilo C., Fang H., Lukashevich V., Keefe D. L. , "Aliskiren monotherapy lowers blood pressure more effectively than ramipril monotherapy in patients with diabetes and grade 2 hypertension: Subgroup analysis of an 8-week, double-blind trial", 18th Annual Meeting of the European-Society-of-Hypertension/22nd Scientific Meeting of the International-Society-of-Hypertension, Berlin, Almanya, 14 - 19 Haziran 2008, cilt.26
dc.identifier.other	vv_1032021
dc.identifier.other	av_739252fd-92b7-44af-90a0-7d6b0eb576d3
dc.identifier.uri	http://hdl.handle.net/20.500.12627/79483
dc.language.iso	eng
dc.subject	Sağlık Bilimleri
dc.subject	Klinik Tıp (MED)
dc.subject	Tıp
dc.subject	Klinik Tıp
dc.subject	PERİFERAL VASKÜLER HASTALIĞI
dc.title	Aliskiren monotherapy lowers blood pressure more effectively than ramipril monotherapy in patients with diabetes and grade 2 hypertension: Subgroup analysis of an 8-week, double-blind trial
dc.type	Bildiri
dc.contributor.department	Baylor Clin , ,
dc.identifier.volume	26
dc.contributor.firstauthorID	134999

Bu öğenin dosyaları:

Dosyalar	Boyut	Biçim	Göster
Bu öğe ile ilişkili dosya yok.